Epidemiology of primary paediatric brain tumours at Johannesburg and Chris Hani Baragwanath hospitals from April 1995 to April 2005 by Nkusi, Agabe Emmy
EPIDEMIOLOGY OF PRIMARY PAEDIATRIC BRAIN TUMOURS 
AT JOHANNESBURG AND CHRIS HANI BARAGWANATH 
HOSPITALS FROM APRIL 1995 TO APRIL 2005 
 
 
 
 
 
 
 
 
 
 
 
 
AGABE EMMY NKUSI 
Student number:  0010894T 
 
 
 
 
 
 
 
 
 
 
 
 
A research report submitted to the Faculty of Health Sciences, University of 
the Witwatersrand, in partial fulfilment of the requirement for the degree of 
Master of Medicine in the branch of Neurosurgery, Johannesburg, 2008 
 ii
DECLARATION 
 
I, Agabe Emmy  Nkusi, declare that this research report is my own work.  It is 
being submitted for the degree of Master of Medicine (Neurosurgery) of the 
University of the Witwatersrand, Johannesburg. 
 
It has not been submitted before for any degree or examination at this or any 
other University. 
 
 
 
 
 
________________________________ 
(Signature) 
 
 
 
 
_________ day of ________________ 2008. 
 iii
DEDICATION 
 
To Anita my wife, and children, Daniel, Andrew and Natasha for their love, 
patience and support. 
 iv
ABSTRACT 
 
Epidemiology of primary paediatric brain tumours has been studied extensively in 
developed countries of the west.  Such studies are lacking in developing 
countries especially sub-Saharan Africa. 
 
This study seeks to establish the epidemiology of primary brain tumours seen 
among children that were treated at Chris Hani Baragwanath and Johannesburg 
Hospitals from April 1995 to April 2005. 
 
The records of 252 patients who presented with this condition during the study 
period were reviewed, for the following details: 
 
● Demographic details such as age, gender and race 
● Diagnosis and the date when it was made 
● The follow-up period at the hospital(s)/clinic(s) 
● The anatomical location of the tumours; supratentorial or infratentorial 
● The treatment that was given which included mainly surgery for tumour 
removal or biopsy, radiotherapy, chemotherapy and others which included 
ventriculoperitoneal shunt, external ventricular drain insertion. 
● The outcome of treatment included:  
- alive 
- dead 
- presumed alive  
- lost to follow-up 
 
It was found: 
 
● That 225 patients had full demographic details of race, gender and age.   
● That there was a slight male predominance among children with primary 
brain tumour. 
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● That the majority of children with brain tumours were black, followed by 
whites which is in keeping with the country’s demographics. 
● The three most common tumours were astrocytomas, medulloblastomas 
and brainstem gliomas in the descending order of frequency. 
● Medulloblastomas were the commonest tumours in the infratentorial 
region while craniopharyngiomas were commonest tumours in the 
supratentorial region. 
● More children had infratentorial tumours 
● Younger children were more likely to have infratentorial tumours. 
● Majority of patients had surgery either for diagnosis or for diagnosis and 
treatment. 
● Few patients were presumptively diagnosed clinically and by imaging 
modalities 
● Combination therapy of surgery, chemotherapy and radiotherapy had the 
best survival outcome while chemotherapy as the only form of treatment 
had the worst outcome. 
● The overall 5 year survival rate for all the study participants was much 
lower than that of their counterparts in the literature. 
● Children who had craniopharyngiomas and astrocytomas had better 
survival. 
● Mortality incidence was slightly higher for whites than blacks but that could 
have been skewed by a high number of blacks that was lost to follow-up. 
● A higher infratentorial tumour prevalence than in the literature was noted. 
 
It was noted that racial prevalence of primary paediatric brain tumours follows  
population demographics. 
 
From the results of this study, there is a need for a better record keeping and  
improved patients follow-up. 
 
There is also a need for a larger epidemiological study in the two hospitals. 
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There is need to establish a specialized paediatric unit which will help start a  
paediatric team comprising of a paediatric neurosurgeon, paediatric oncologist,  
paediatric intensivist and neuroradiologist with dedicated neuropaediatric ICU.   
Such a team given resources will improve survival outcome of children with brain  
tumours. 
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DEFINITION OF TERMS 
 
Glioma: In this research report, the term glioma was found to be used as a 
presumptive diagnosis for lesions in brainstem and thalamus based on clinical 
and radiological grounds. 
 
Primitive neuroectodermal (PNET) occurs in both supratentorial and infratentorial 
regions.  The commonest PNET in the infratentorial region is Medulloblastoma.  
In this research report Medulloblastoma is specified from general PNETs by 
writing the name or putting PNET and then Medulloblastoma in blackets. 
1CHAPTER ONE 
 
1.0 INTRODUCTION 
 
1.1 BACKGROUND 
Primary paediatric brain tumours have been studied extensively in the developed 
countries in the last 2 decades, but such studies are few or lacking in the 
developing world.  Comparison of data from the two worlds may not give the true 
picture because of small numbers reported in the developing countries especially 
sub Sahara Africa.  However, one is able to compare the trends of the 
prevalence of the brain tumours. 
 
The author’s experience while working at Chris Hani Baragwanath and 
Johannesburg hospitals regarding national and provincial epidemiology of 
primary paediatric brain tumours was found to be inadequate.  Due to 
inadequacy of epidemiological data on primary childhood brain tumours, the 
author developed interest in studying primary paediatric brain tumours.  The 
epidemiology of primary paediatric brain tumours and the associated morbidity 
and mortality rate are important for counselling and obtaining consent for surgery 
from caregivers and to predict diagnosis, which may influence treatment 
outcome.  These data are particularly important for tertiary hospitals where a high 
number of children with primary brain tumours are referred.  
 
Paediatric brain tumours are the second most common type of cancer after 
leukaemia and the leading cause of mortality among children1.  In the same 
study it was reported that infratentorial tumours comprised 50-55% and were the 
most common.  They comprised of medulloblastomas (20%), astrocytomas 
(15%), brainstem gliomas (10%) and ependymomas (6%).  Supratentorial 
tumours (45 - 50%) were the second common and included astrocytomas (23%), 
malignant gliomas (6%), craniopharyngioma (6%), primitive neuroectodermal 
2tumours (PNET)(4%), pineal region intracranial germ cell tumours (4%), 
ependymomas (3%), and others 4%1. 
 
A Korean study7 found Pilocytic astrocytomas, medulloblastomas, 
craniopharyngiomas and germ cell tumours were commonest of brain tumours. In 
this multicentre study overall male to female ratio of 1.4:1 among children with 
primary paediatric brain tumours was noted. 
Similarly, in a German study by Kaatsch et al6 the most common tumours were 
astrocytomas (41.7%), medulloblastomas(18.1%), ependymomas (10.4%), 
supratentorial PNETs (6.7%) and craniopharyngiomas (4.4%). 
In developing countries, community based epidemiological data about childhood 
primary brain tumours is lacking, and where studies have been done, they 
concentrated on adult central nervous system tumours or on childhood cancers 
in general.  Examples of such studies are: 
 
“Tumours of childhood in Ibadan, Nigeria” by A.Olufemi, W9.  In this study 1325 
cases were analyzed and intracranial tumours were only 29(2.2%).  In the same 
study, the commonest tumours were astrocytomas (37.9%) followed by 
craniopharyngiomas (24.1%),medulloblastomas and pineolomas were of equal 
proportion (10.3%) ependymomas (6.9%) gliomas (3.4%), and teratomas (3.4%). 
 
In a Ghanian study by R K Gyasi,and Y Tettey10, out of 252 cases only 32(13%) 
were brain tumours.The modal age group was 11-14 years with modal age of 
11years. Histological types were gliomas 21(65.6%), meningioma 2(6.3%),and 
pituitary adenoma 1(3.1%).  The histological type was not stated in 25%(8/32) of 
cases.  The male:female ratio for CNS tumours was 1.14:1. 
 
In South Africa and in particular the two tertiary hospitals (Chris Hani 
Baragwanath and Johannesburg), there is little documented epidemiological data 
about paediatric brain tumours.  Sparrow14 in 1986 studied central nervous 
tumours and found only 49 paediatric brain tumours.  The tumour composition 
3was as follows; astrocytomas 26(53%), medulloblastomas 12(25%), 
craniopharyngiomas 7(14%), ependymomas, oligodendrogliomas, meningioma 
and pineal tumours were 1(2%) each. 
 
This study determined the epidemiology of primary brain tumours among children 
treated at Chris Hani Baragwanath and Johannesburg hospitals from April 1995 
to April 2005 by analyzing patients’ records. 
 
1.2 PROBLEM STATEMENT 
 
Although there is literature about epidemiology of paediatric brain tumours in 
other countries, to the author’s knowledge there is no study that has been done 
at the two mentioned tertiary hospitals of Johannesburg and Chris Hani 
Baragwanath to establish such epidemiological data.   
 
This study was carried out so that the prevalence, the type of common tumours, 
treatment modalities and the survival periods are established. 
 
1.3 RESEARCH QUESTION AND OBJECTIVES  
 
1.3.1 Specific questions 
 
What is the epidemiology of primary brain tumours in children of 0 ─14 years? 
 
1.3.2 Specific objectives 
 
(i) To determine the prevalence of primary brain tumours in paediatric age 
group of 0 ─14 years  
(ii) To identify the types and frequency rates of paediatric brain tumours. 
(iii) To establish the common anatomic locations of paediatric brain tumours. 
4(iv) To identify differences in ages affected by different paediatric brain 
tumours. 
(v) identify various treatment modalities used in the management of paediatric 
brain tumours 
(vi) To establish the mortality and survival rates associated with childhood 
brain tumours. 
 
1.4 SIGNIFICANCE 
 
The information gained from the study will be valuable in the management of 
subsequent patients, planning for treatment and further managerial follow-up of 
the children with primary paediatric brain tumours.  
Furthermore, the information gained will be important to obtain informed consent 
from caregivers including parents and guardians. These data will be used in the 
appropriate management of patients with similar conditions while explaining the 
possible diagnoses and possible treatment outcomes. 
 
In comparison with data from other countries and institutions, different treatment 
options that have been proven effective elsewhere would be introduced to 
improve the treatment outcome among the affected children. 
 
The author is optimistic that these data will contribute in future management of 
children with brain tumours and that it will stimulate more research in this field.  
 
5CHAPTER TWO 
 
2.0 LITERATURE REVIEW 
 
2.1 PREVALENCE OF PAEDIATRIC BRAIN TUMOURS 
 
Primary paediatric brain tumours have been studied extensively in the developed 
countries in the last 2 decades, but such studies are few or lacking in the 
developing world.  Comparison of data from the two worlds may not give a true 
picture because of small numbers reported in the developing countries especially 
sub Saharan Africa. However, one is able to compare the trends of the 
prevalence of the brain tumours and other epidemiological data.  In this chapter, 
larger studies are considered first because of their significance, and then studies 
from other African countries and finally the South African studies are reviewed. 
. 
Brain tumours are the most common group of solid tumours in childhood 
according to studies in the developed countries of USA, Europe and Japan1,2,8,3. 
It is also evident that children with brain tumours have a relatively poor survival 
rate5. In most countries the commonest childhood tumours are leukemias 
followed by brain tumours4,8. The childhood brain tumours typically account for 
about 20-25% of all childhood cancers4,8. 
 In a study by Stiller CA and Parkin DM4, the most common category of CNS 
tumour in childhood was astrocytoma, followed by medulloblastomas, while 
ependymomas were rare.  
 
Greta R.Bunin2 also reported that the commonest brain tumours are 
astrocytomas and primitive neuroectodermal tumour (PNET)/ medulloblastomas, 
which accounted for about 50% and 20% of childhood brain tumours 
respectively. 
 
6Similarly, Melissa and Julianne8 showed that from 1975 to 1995 astrocytomas  
accounted for 52% of central nervous system malignancies, primitive 
neuroectodermal tumour [PNET] including medulloblastomas 21%, gliomas 15%, 
ependymomas 9%, and other CNS tumours 3%.  These authors also reported 
that the overall annual incidence in the United States of paediatric malignant 
CNS tumours was about 28 per million in children younger than 14 years of age.  
Primary malignant tumours of the central nervous system were found to account 
for about 16% of childhood malignancies6 and it was found to account for about 
19 – 22 % of all reported incidences of malignancies in children1.  
 
Feltbower et al5 in their study on the epidemiology of central nervous system 
tumours in children and young adults (0-29years), reported a higher incidence of 
childhood CNS tumours at 32.7 (28.9-36.5) per million compared to the 28 per 
million of USA8. They also found that astrocytomas and medulloblastoma/PNET 
comprised the majority of childhood CNS tumours at 41% and 25% respectively. 
 
A German study by Kaatsch et al6 on epidemiology of brain tumours in German 
children, like other studies from developed countries, found the incidence rate of 
2.6 per 100,000(26 per million).  They also found that the most common brain 
tumours were astrocytomas (41.7%), medulloblastomas (18.1%), ependymomas 
(10.4%), supratentorial PNETs (6.7%) and craniopharyngiomas (4.4%). 
 
In a Korean Study by Suh et al7 on central nervous system tumours, 3221 cases 
were studied and only 273 (8.5%) cases were children under 15 years of age.  
Pilocytic astrocytomas, medulloblastomas, craniopharyngiomas, germ cell 
tumours and ependymomas were common types of tumours found. 
 
In a Nigerian study by Olufemi A9 on tumours of childhood in Ibadan, a total of 
1325 children with cancer were analyzed.  In this study, intracranial tumours 
accounted for only 2.2% (29). They comprised astrocytomas 37.9%, 
craniopharyngiomas 24.1%, medulloblastomas and pineolomas each at 10.3%, 
7ependymomas 6.9%, gliomas and intracranial teratomas each at 3.4%.  Contrary 
to studies from western countries, lymphomas were more than leukemias at 59% 
and 4.5% respectively, of the total childhood cancers. 
 
Gyasi and Tettey10 in their study on childhood deaths from malignant neoplasms 
in Accra found most common malignancy was lymphoma at 54% of cases 
followed by CNS tumours at 13%.  Leukemias were fourth common at 6.7%.  
Gliomas (65.6%) were the most common brain tumours, meningiomas (6.3%), 
and pituitary adenoma (3.1%). Histologic types were not stated in 25% of 
cases10. 
 
Wiredu and Armah11 in their study on cancer mortality patterns in Ghana, 
analysed 375 children (<15 years), and only 19 children had brain tumours.  The 
commonest cause of death was reported to be haematopopoietic in origin (57.8% 
in females and 60.3% in males.). 
 
Wessels and Hesseling12 studied the incidence and frequency rates of childhood 
cancer in Namibia.   
 
In this study, central nervous system CNS) tumours occurred most commonly 
(18%), followed by renal tumours (14%), leukaemia 9(12%) and lymphoma 
(11.5%).  The incidence rate of CNS tumours was only 9.3 per million, much 
lower than that reported in western countries2,3,4,5,6,7,8. 
 
In a study by Peacock, Lazareff and Levin13, 145 cases were studied.  Ninety one 
(63%) were infratentorial while 54(37%) were supratentorial in location. Of the 
supratentorial tumours 24(44.4%) were in parasellar region, 14(24.9%) in 
cerebral hemispheres, 8(14.8%) in pineal region and 4(7.4%) in third ventricles. 
The posterior fossa included medulloblastomas (41.8%), brainstem gliomas 
(25.3%), ependymomas (16.5%) and cerebellar astrocytomas (15.4%). 
 
8In Sparrow’s14 report out of 49 cases, 26(53%) were astrocytomas, 12(25%) 
medulloblastomas, 7(14%) craniopharyngiomas and only 1 case (2%) each for 
ependymoma, oligodendroglioma, meningioma and pineal tumours. 
 
2.2 AGE DISTRIBUTION  
 
The overall prevalence of central nervous system (CNS) tumours is highest in 
children younger than 8 years of age8. The difference was attributed to cerebellar 
PNET [medulloblastoma], brainstem gliomas and ependymomas that occur 
almost exclusively in children less than 10 years old. According to these authors, 
the average annual incidence of CNS cancer between 1986 to 1994 varied only 
slightly by age of diagnosis from infancy through age 7 years [36 per million].  For 
all CNS tumours from age 7 to 10 years, a 40% drop in the incidence rate was 
observed, with a slight increase from ages 10 to 12, and a second decline from 
ages 12 to 20.  For all ages the incidence of astrocytomas was highest, peaking 
at age 5 and 13 years [70 per million].  For ages 0 - 3 years PNET and 
ependymoma rates were highest [11 and 7 per million respectively] and then 
steadily declined.  Gliomas had the lowest incidence during infancy with peaks at 
ages 8 and 17[9 and 7 per million].  Overall, ependymoma was the rarest type of 
brain tumour in children ages 3 to 20 years. 
 
Olufemi9 in his study reported that children with gliomas were over the age of 7 
years. 
Gyasi and Tettey10 reported that the modal age group for childhood  CNS 
neoplasms  was 11-14 years with a modal age of 11 years . 
 
Wessel and Hesseling12 found the median age for children with central nervous 
system (CNS) tumours to be 7.8 years, similar to that found in Nigerian9 children 
and much lower than among children in Ghana10. 
92.3 GENDER DISTRIBUTION 
 
Melissa and Julianne8 in their study, reported overall incidence of invasive CNS 
tumours between 1990 - 1995 for children ages 0 – 20 years was 24% higher in 
males than females, with rates of 30 and 24 per million respectively.  PNETS 
showed the largest difference between males and females, followed by 
ependymomas.  There were more males than females with CNS tumours for both 
white and black children, with greater difference between boys and girls seen 
among white children8. 
 
Feltbower et al5 reported a male:female ratio of 1.3:1 and a striking sixfold male 
excess was observed for ependymomas in children aged under 10 years. 
 
In a Korean multicentre study7, the overall male to female ratio of 1.4:1 among 
children with brain tumours was observed.  Furthermore, most tumour types in 
children showed a distinct predilection for males with exception of pilocytic 
astrocytomas [0.7:1], which was more common in girls than boys. 
 
In one study on childhood cancer in Nigerian9 children, it was demonstrated that 
children with gliomas had equal sex distribution. Craniopharyngiomas were also 
predominant in male children under the age of 5 years.9 On the other hand, in 
Ghanian10,11 studies male to female ratio for tumours was 1.14:1 and 1.26:1 
respectively. 
 
2.4 RACE DISTRIBUTION  
 
Melissa and Julianne8 while studying epidemiology of brain tumours in children 
found that CNS tumours are more common in white children compared to black 
children, with an 18% higher rate between 1990 -1995.  The greatest difference 
was seen in white males at a 26% higher rate, compared to an 8% higher rate for 
white females. 
10
Stiller and Parkin 4 also found that black children in Britain have significantly low 
relative frequency of brain tumours than their white counterparts. 
 
2.5 ANATOMIC LOCATIONS  
 
Kline and Sevier 3 in their study on solid tumours in children found that 
approximately 55% of the tumours arose in the posterior fossa, and 45% were 
supratentorial.  Kaatsch et al6 reported a nearly equal tumour distribution 
between supratentorial and infratentorial regions.  They reported that, among 
children with infratentorial tumours, 56.0% had ependymomas, and 44.0% had 
astrocytomas.  Among children with PNETs, 70.2% had infratentorial PNETs 
(medulloblastoma), and 26.0% supratentorial PNETs.  
 
In the group of children with other brain tumours, Supratentorial tumours were 
preponderant.  Suh et al7 reported 42% of paediatric brain tumours to be 
infratentorial and 68% to be supratentorial contrary to reports from western 
countries3,6.  Peacock et al13 in their study “childhood brain tumours in Cape 
Town” found that 63% of the tumours were located in the infratentorial region and 
37% in the supratentorial region. 
 
2.6 MORTALITY AND SURVIVAL RATES ASSOCIATED WITH 
PAEDIATRIC BRAIN TUMOURS 
 
Melissa S and Julianne B8 in their study on the epidemiology of brain tumours in 
children reported that although children with malignant CNS tumours did not 
have as favourable prognosis as children with other cancers, 5 year relative 
survival rates increased from 59% between 1975 -1984 to 67 % between 1985 -
1994.  During these time periods, the greatest increase in survival by age was 
seen in ages 15-19 by 10 % [from 67 - 77 %] with only 2 % increase in ages 0 - 5 
[from 54 -56 %].  Males had a greater increase in survival of 9% compared to 2% 
for females.  White and black children had similar increase in survival of 6% and 
11
5% respectively.  These increases were seen in all tumour types with the 
greatest improvement in ependymomas [39 % to 56 %], followed by gliomas 
[46% to 57%].   
 
Survivors of paediatric brain tumours may have significant long-term morbidity 
from their disease and treatment.  Fortunately, survival rates for childhood CNS 
tumours continues to be on the rise as improvements in therapy are being 
pursued to improve patient survival. 
 
Kline and Sevier3 reported that survival rate for children with brain tumours varies 
widely depending on histology, degree of surgical resection, and level of 
metastasis. 
 
Feltbower et al5 reported one-and 5-year survival rates for children 0-14 years 
with CNS tumours as 82% and 67% respectively. 
 
Similarly, Kaatsch et al6 reported a 5 year survival of 64% for all brain tumours 
which is comparable to that from other developed countries.  Of the most 
frequent brain tumours, children with craniopharyngiomas had the best prognosis 
(10-year survival rate ,87%) followed by children with astrocytomas (73%).  
Within 10 years after diagnosis more than 50% of children with ependymomas, 
medulloblastomas and supratentorial PNETs had died.  Kaatsch et al6 also 
reported that for the whole group of children with brain tumours, girls showed a 
somewhat better prognosis than boys.  They also found in the same study that 
CNS tumours showed somewhat a better prognosis with increasing age. 
 
According to the above literature review, the need for an epidemiological study of 
brain tumours among children in South Africa became necessary to establish the 
prevalence, types, locations, treatment options used and outcomes of the 
different brain tumours.  This will help clinicians in proper planning of treatment 
and also the government in availing resources.  Knowledge of the disease 
12
problem will help in establishing public awareness of brain tumours and this will 
in turn help in early diagnosis of the tumours and treatment which in turn 
improves survival rates. 
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CHAPTER THREE 
 
3.0 METHODOLOGY 
 
3.1 STUDY SETTING 
 
The target population comprised of all children between 0 and 14 years of age, 
treated at Chris Hani Baragwanath and Johannesburg Hospitals with diagnoses 
of primary brain tumours from April 1995 to April 2005. 
 
Chris Hani Baragwanath is the largest hospital in South Africa and one of the 
largest hospitals in sub-Saharan Africa.  It is located in South-Western townships 
(SOWETO) in Johannesburg.  It serves as a teaching hospital of the University of 
the Witwatersrand, and as a tertiary hospital for Gauteng Province.  Chris Hani 
Baragwanath hospital serves mainly the black poor living in SOWETO and the 
surrounding areas who often do not have medical insurance facilities.  Besides 
being a referral hospital for smaller hospitals in Gauteng, it also serves as a 
referral hospital for Mpumalanga and North West provincial hospitals particularly 
for neurosurgical conditions.  
 
Johannesburg hospital is also a teaching hospital of the University of the 
Witwatersrand, and also serves as tertiary hospital for Gauteng Province.  
However, the hospital serves both the poor and middle class people who may 
have medical insurance facilities. It is located in Johannesburg city, and further 
serves as a neurosurgical referral for other provincial hospitals in Mpumalanga 
and North West provinces.  
 
Consequently, it was important for the author to study epidemiology of primary 
paediatric brain tumours at Chris Hani Baragwanath and Johannesburg Hospitals 
since these are the largest and major referral hospitals for neurosurgical 
14
conditions in Johannesburg and surrounding areas, and therefore information 
obtained from this study was considered to be representative of the greater 
Johannesburg and surrounding areas’ population. 
 
3.2 STUDY DESIGN 
 
A retrospective study design was used to study the epidemiology of primary 
paediatric brain tumours from April 1995 to April 2005.   
 
A review of patients’ records enabled the author to establish the epidemiology of 
paediatric primary paediatric brain tumours among the study population. The 
author considered this ten-year period of follow-up to be adequate and the 
neurosurgical conditions received at the hospitals during that time was 
considered to be a representative sample of the communities served by the 
hospitals.  
 
Data from a retrospective study is fairly representative and minimizes possibilities 
of bias compared to a cross-sectional study. 
 
3.3 STUDY POPULATION 
 
Children that were admitted to Chris Hani Baragwanath and Johannesburg 
hospitals during the period April 1995 to April 2005 with diagnoses of primary 
brain tumours were studied. 
 
3.3.1 Inclusion criteria 
 
Children were included if they met the following criteria: 
● Male or female children between ages 0 and 14 years with primary brain 
tumours 
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● Children admitted to Chris Hani Baragwanath and Johannesburg 
Hospitals between April 1995 and April 2005. 
 
3.3.2 Exclusion criteria 
 
The following subjects were excluded: 
● Children with brain tumours other than primary brain tumours  
● Children above 14 years. 
● Children with incomplete records. 
 
3.4 SAMPLES AND SAMPLING METHODS 
 
There was no sampling of subjects to include in the study.  All children who 
fulfilled inclusion criteria with primary brain tumours between 0 and 14 years 
admitted to Baragwanath and Johannesburg hospitals between April 1995 and 
April 2005, were studied.  
 
3.5 INSTRUMENTS  
 
Data capture sheet based on study objectives was developed (Annex 1) and 
used.  Data obtained from the retrospective review included subjects’ 
demographics, number and type of tumours, anatomic locations of the tumours, 
treatment modalities and follow-up period.   
 
The demographic data particularly assessed different age groups, gender and 
races of the subjects.  Demographic data together with follow-up period were 
used to ascertain mortality and survival rates associated with childhood brain 
tumours. 
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3.6 DATA ANALYSIS 
 
Data was entered into Microsoft Excel where preliminary cleaning was done 
before being transferred to STATA version 9.0 where more data management 
and all statistical analyses were carried out.  Graphs were plotted using both 
Excel and STATA version 9.0 programs.   
 
Descriptive statistics were first carried out for key variables.  The descriptive 
statistics employed depended on the variable.  Means and standard deviations 
were used for continuous variables while proportions and graphs were used for 
categorical variables.   
 
Statistically significant differences in continuous variables were assessed using 
the Student t-test while for categorical variables, the Chi-squared test was used.  
Test for significant difference were done at a confidence level of 0.05.  A p-value 
less than 0.05 indicated a statistically significant finding. 
 
For mortality from brain tumours, incidence rates and Kaplan-Meier survival 
estimates were carried out using survival analysis.  Incidence rate and Kaplan-
Meier survival curves were estimated for all study participants for whom time of 
follow-up information was available, and were also estimated by key explanatory 
variables including diagnosis and treatment received.   
 
A participant’s person-years (py) is length of time for which the participant was 
under observation.  For participants who were still alive, length of time of 
observation was truncated at the end of the study period of 30th April 2005. 
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3.7 ETHICAL CONSIDERATIONS 
 
Considerations to protect the rights of human subjects and standards of any 
scientific enquiry were taken into consideration.   
 
However, since this study was a retrospective study there was no direct contact 
with the subjects.  Permission was obtained from hospital administration at Chris 
Hani Baragwanath and Johannesburg Hospitals where the study took place 
(Annexes 2 and 3).  Besides, ethical clearance (number M051128) was obtained 
from ethics committee at University of the Witwatersrand (Annex 4).  
 
Although this study was a retrospective review of subjects’ records without direct 
contact with patients, data remained anonymous.  The author will make all 
attempts to share the data findings obtained from this study are shared with 
various professional colleagues, such as those at University of the 
Witwatersrand, Baragwanath and Johannesburg hospitals.  The author will 
endeavour to write articles for publications in professional peer review journals.  
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CHAPTER FOUR 
 
4.0 RESULTS 
 
4.1 INTRODUCTION 
 
This chapter comprises the following sub-sections: 
(i) Description of study participants  
(ii) Types and frequencies of brain tumours by age and location 
(iii) Description of treatment modalities used in the management of primary   
paediatric brain tumours  
(iv) Mortality incidence presented by crude proportion of all participants 
(v) Refined incidence rate by person years and survival estimates 
 
4.2 DESCRIPTION OF STUDY PARTICIPANTS  
 
Initially, 348 children were found to have had primary brain tumours from April 
1995 to April 2005 with 196(56.3%) at Chris Hani Baragwanath hospital and 
152(43.7%) at Johannesburg hospital.  One hundred twenty three (35.5%) were 
excluded because they did not meet the inclusion criteria.  A total of 225 
participants were included in this study. 
 
4.2.1 Subjects’ demographic characteristics (n= 225) 
 
Table 4.2.1 shows subjects’ demographic characteristics. There was a significant 
difference in race distribution of tumours, with the majority of tumours (n=182) 
affecting blacks (80.9%).  Thirty four (15.1%) of tumours affected the whites and 
the least affected were the coloured (n=5, 2.2%) and the Asians (n=4, 1.8%).  
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The mean age of the study participants was 7.1 years with a standard deviation 
of 3.8 years.  The youngest participant was 0.2 years while the oldest was 14 
years. 
 
One hundred and fifteen (52.1%) of the subjects were males and one hundred 
and ten were females (48.9%).  The male to female ratio was 1.05:1. 
 
Table 4.2.1. Subjects’ gender and race characteristics  
Characteristics    n % 
Gender   
Males 115 52 
Females 110 48 
Race   
Black 182  80.9 
Asian  4  1.8 
White 34 15.1 
Coloured  5  2.2 
n=number; %= percentage 
 
4.3 RELATIVE PREVALENCE FOR DIFFERENT TYPES OF BRAIN 
TUMOURS 
 
 
Table 4.2.2 shows the prevalence of paediatric brain tumours.  The commonest 
brain tumours were astrocytomas (25.7%), whereas medulloblastomas (21.2%) 
were second commonest, followed by gliomas (brainstem and thalamic) (19.9%), 
craniopharyngiomas (11.5%) and ependymomas (7.5%).  The rare ones were 
meningiomas (0.9%), pituitary adenomas (0.9%) and gangliogliomas (0.9%). 
 
About eighty percent (80.1%)of the tumours were histologically diagnosed.  The 
remainder, the gliomas (19.9%) were diagnosed clinically and by imaging 
techniques.  The commonest imaging modality used was magnetic resonance 
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imaging (MRI). Gliomas were diagnosed using MRI because they are found in 
deep and delicate structures; brainstem and thalamus.  
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Table 4.2.2: Prevalence of primary paediatric brain tumours 
 
Diagnosis  Relative prevalence (%) Confidence Interval (CI) 
Medulloblastoma 21.2 16.1 – 27.1 
Glioma 19.9 14.9 – 25.7 
Astrocytoma 25.7 20.1 – 31.9 
Ependymoma 7.5 4.4 – 11.8 
Craniopharyngioma 11.5 7.7 – 16.4 
Meningioma 0.9 0.1 – 3.2 
Pituitary adenoma 0.9 0.1 – 3.2 
Ganglioglioma 0.9 0.1 – 3.2 
PNET 3.5 6.2 – 14.4 
Pineoblastoma 8.0 0.5 – 4.5 
PNET, Primitive neuroectodermal tumour, Glioma =Brainstem gliomas+thalamic 
gliomas.    
 
 
4.4  ANATOMIC LOCATIONS OF THE TUMOURS  
 
 
Intracranial cavity is divided into two parts, namely, supratentorial and 
infratentorial regions.  This was done to facilitate tumour analysis in different 
locations. 
 
Majority of the tumours were found in the infratentorial region (67%) whereas the 
supratentorial region comprised the remaining 33%.  There were 151 (67%) 
infratentorial and 74 (33%) supratentorial brain tumours. 
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Figure1: The different anatomic locations of childhood brain tumours. 
 
 
4.4.1 Tumours in infratentorial region  
 
 
The majority of the tumours (67%) were found in the infratentorial region. 
Medulloblastomas were the commonest (34%), followed by brainstem gliomas 
(30%), astrocytomas (19%), ependymomas (12%), and PNET (other than 
medulloblastoma) were only 5%. 
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Types of brain tumours in the infratentorial region
PNET
5%
Ependymoma
12%
Astrocytoma
19%
Glioma
30%
Medulloblastoma
34%
 
 Figure 2: Brain tumour profiles in the infratentorial region of the brain 
 
 
4.4.2 Tumours in the supratentorial region 
 
This region had the highest number of histochemically diagnosed tumours 
because of easy accessibility of most parts in this region which is exemplified by 
the low number of gliomas (4.2%). 
 
The commonest tumour in the supratentorial region was craniopharyngiomas 
(36.6%), followed by pineoblastomas (25.4%), astrocytomas (21.1%), gliomas 
(4.2%) and the remaining tumours comprising of supratentorial PNET, pituitary 
adenomas, gangliogliomas, ependymomas and meningiomas making the 
remaining 12.6%. 
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Figure 3: Brain tumour profiles in the supratentorial region of the brain 
 
 
4.5 AGE AND BRAIN TUMOUR DISTRIBUTION 
 
 
Figure 4 shows tumour distribution in different age groups.  Participants’ age 
groups were as follows: 0-2.0 years, 2.1-6.0 years, 6.1-9.0 years, 9.1-12.0 years, 
and 12.1-14.0 years. Different tumours affected different age groups differently. 
For example, medulloblastomas affected all children, and the most affected 
children were in the age groups between 2.1 and 9.0 years.   
 
Gliomas included mainly brainstem gliomas which were over 90%, the others 
were thalamic gliomas. In this study group, gliomas affected ages from 0 to 12 
years, and the most affected age group was 2.1 to 6.0 years.  
 
Astrocytomas affected all age groups but peaked in age group 2.1 to 6.0 years 
and started slowly to decline.   
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Ependymomas affected all age groups but peaked in the age group of 2.1 to 6.0 
years and then peaked again in the age group of 9.1 to 12.0 years.  
 
Craniopharyngiomas affected mainly ages between 2 to 12 years.   
 
Pineoblastomas were common among ages between the age 6 to 14 years. 
PNETs other than medulloblastomas and pineoblastomas affected mainly 
children of ages between 2 to 12 years, and were uncommon between the age 
groups of 0 to 2.0 years and 12.1 -14 .0 years.   
 
The numbers for pituitary adenomas, meningiomas and gangliogliomas were too 
small to be analysed. 
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Figure 4: Subjects’ age groups in relationship to the types of brain 
tumours  
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Age seems to affect the location of brain tumours in children (Table 4.5.1.).  The 
mean age of the subjects who had brain tumours in the supratentorial location 
was significantly higher than the mean age of those who had brain tumours in the 
infratentorial location.  
 
Also, there was a significant difference between age distribution of supratentorial 
brain tumours (7.9 ± 0 45) and Infratentorial brain tumours (6.4 ± 0.32) (p=0.009). 
 
An epidemiological cross-tabulation was then carried out to quantify this risk of 
brain tumour location by age.  The 2 by 2 table below (table 4.5.1) revealed that 
children who were older than 7 years were about 2.4 times more likely to have a 
supratentorial brain tumour than children who were younger. 
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Table 4.5.1: The Odds ratio of anatomical location of brain tumour by age group 
 
 Supratentorial Infratentorial Total 
Older than 7 41 (44.6) 51 (55.4)  110 
Younger than 7 28 (25.5) 82 (74.6) 92 
Total 133 (66) 69 (34) 202 
Data is presented as n (%) OR = 2.35 (95% CI = 1.28 – 4.32), p-value = 0.004. 
 
4.6 DIFFERENT TREATMENT MODALITIES EMPLOYED 
 
Figure 5 shows different treatment modalities which were employed in the 
management of primary paediatric brain tumours.  Majority of participants were 
treated by surgical intervention alone (49.2%).   
 
During surgery, either a total tumour was removed and required no other 
treatment or surgery was followed by other treatment modalities, radiotherapy or 
chemotherapy or a combination of the two modalities.  Ten percent of the 
participants received radiotherapy alone.  These were children diagnosed with 
brainstem gliomas.  Chemotherapy was used for subjects who had braistem 
gliomas but were 3 years or younger and could not receive radiotherapy. 
 
Combination therapy: This modality of treatment was commonly given to subjects 
with malignant tumours.  In this study group combination therapy comprised 
25.5%. 
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Figure.5 The different treatment modalities that were used. 
 
4.7 MORBIDITY AND MORTALITY FROM CHILDHOOD BRAIN TUMOURS 
 
Outcome was defined as: 1) Died, 2) Alive (alive at the end of study follow-up – 
30 April 2005), 3) Presumed alive (Fact of death is unknown – patient discharged 
or last known to be alive before end of study follow-up), and 4) lost to follow-up 
(No data on discharge date or outcome).   
 
Figure 6 shows overall outcome from childhood brain tumours.  
 
Figure 7 also shows survival outcome by race groups. 
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4.7.1 Overall outcome 
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Figure 6 The overall outcome from childhood brain tumours 
 
Outcome information is not available for about half of the study participants while 
24% were dead (cumulative incidence in mortality) and 10% were alive while16% 
of study participants were presumed alive. 
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4.7.2 Outcome by race 
Survival outcome by race
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Figure 7 shows survival outcome by race groups. 
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4.7.3 Outcome by gender 
 
Survival outcome by gender
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Figure 8 shows outcome by gender 
 
The pattern of mortality is similar for males and females.  
 
4.7.4 Outcome by treatment modalities 
 
This study showed that the best of treatment modalities was combination therapy 
of surgery, radiotherapy and chemotherapy where 38.8% were alive at the end of 
the study, whereas the worst was treatment by chemotherapy alone where there 
were no survivors. 
 
32
Table 4.7.1.Outcome by treatment in percentage  
 
Treatment 
 
n 
Percentages (%) 
Dead Alive Pre-
alive 
Lost to 
FU 
Surgery 88 13.6 4.6 20.5 61.4 
Radiotherapy 18 50.0 11.1 33.3 5.6 
Chemotherapy 6 66.7 - 16.7 16.7 
Surgery/Radiotherapy 15 33.3 13.3 20.0 33.3 
Surgery/Chemotherapy 7 14.3 28.6 - 57.1 
Chemotherapy/Radiotherapy 4 50.0 25.0 - 25.0 
Surgery/Chemotherapy/Radiotherapy 17 22.2 38.9 - 38.9 
Other modalities 23 43.5 26.1 8.7 21.7 
n=number, FU=Follow-up, Pre-alive=Presumed alive 
 
4. 7.5 Outcome by diagnosis 
 
When one considers outcome based on diagnosis table 4.7.2.  It is difficult to  
make a proper assessment because of a big number of study participants who  
were lost to follow-up.  Different methods were used to analyse the data as  
shown in the following subsections. 
 
33
Table 4.7.2. Outcome by diagnosis in percentage  
 
Diagnosis 
 
n 
Percentages (%) 
Dead Alive Pre-alive Lost to FU
Medulloblastoma 48 25 21.8 10.4 43.8 
Glioma (brainstem + 
thalamic) 
45 40 6.7 15.6 37.8 
Astrocytoma  58 8.6 6.9 24.1 60.3 
Ependymoma 16 29.4 17.7 5.9 47.1 
Craniopharyngioma 26 15.4 7.7 23.1 53.9 
Meningioma  2 - - - 100 
Pituitary adenoma 2 - 50 - 50 
Ganglioglioma 2 50 - - 50 
PNET  8 25 - 12.5 62.5 
Pineoblastoma 18 38.9 11.1 5.6 44.4 
PNET= Primitive neuroectodermal tumours  
 
4.8 MORTALITY INCIDENCE 
 
For this analysis of mortality incidence and survival analysis, persons lost to 
follow-up were excluded from the analysis as no further visit information was 
available for them after first report to the hospital.  As a result, there were no 
person years of follow-up information on them.  
 
It is however, assumed that the survival outcome in persons for which data was 
available might not be different from those lost to follow-up.  Person- years is 
total length of time for which a participant was under observation.  For 
participants still alive, length of time was truncated at the end of the study period; 
30th April 2005.  Incidence of mortality was done using Poisson regression. 
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4.8.1 Overall mortality incidence 
 
Total person years of observation (n = 114) = 207.7 years (min = 0.005 and max 
= 8.5 years) 
 
Mortality cases = 60 
Incidence of mortality = 28.4 per 100 person years (95% CI; 21.6 – 36.6).  These 
results indicate that if 100 people diagnosed with a brain tumour were followed 
up (100 person-years), about 28 of them will die in a year.  
 
Table 4.8.1 Mortality incidence by race and gender 
Variable *IR (per 100 person 
years) 
95% CI 
Race   
Blacks 26.2 19.1-35.2 
Whites 32.6 16.8-58.9 
Asian 61.6  7.4-222.7 
Gender   
Males 27.8 18.9-39.4 
Females 29.1 19.3-42.1 
*Incidence rate 
 
Table 4.8.1 Shows mortality incidence rate being higher among whites 32.6 per 
100 person years (CI 16.8-58.9) compared to blacks 26.2per 100 person years.  
The numbers for Asians and coloured were too small for analysis (non-
significant). 
 
Also, this study showed that there was more mortality incidence among females 
than males, 29.1 and 27.8 per 100person years respectively (non-significant). 
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Table 4.8.2 Mortality incidence by diagnosis 
Treatment  *IR (per 100 person 
years) 
95% CI 
Medulloblastoma 16.0 8.3-27.9 
Glioma (Brain Stem + 
thalamic 
67.8 40.2-107.1 
Astrocytoma 15.6 5.1-36.4 
Ependymoma 65.2 17.8-167 
Craniopharyngioma 18.8 5.1-48 
Meningioma *  
Pituitary adenoma *  
Ganglioglioma *  
PNET *  
Pineoblastoma 32.9 13.3-67.9 
- No event    * negligible no of person-years 
 
Table 4.8.2  Shows mortality incidence rate being highest among children with  
gliomas 67.8 per 100 person years followed by ependymomas, 65.2 per 100  
person years and pineoblastomas, 32.9 per 100 person years.   
Craniopharyngiomas, medulloblastomas and astrocytomas had low mortality  
incidence rates,18.8,16.0 and 15.6 per 100 person years respectively.                                              
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Table 4.8.3 Mortality incidence by treatment modality 
 
Treatment Proportion (%) 95% CI 
Surgery 21.3 11-37.1 
Radiotherapy 55.8 25.5-105.8 
Chemotherapy 83.9 22.9-214 
Surgery/Radiotherapy 32.6 10.6-76.1 
Surgery/Chemotherapy *  
Chemotherapy/Radiotherapy *  
Surgery/Chemotherapy/Radiotherapy 9.8 2.6-25.1 
Other modalities 21.6 10.3-39.7 
 
 
4.9 WAITING TIME TO MORTALITY – KAPLAN-MEIER SURVIVAL CURVE 
 
Figure 9 shows general survival estimates for primary childhood brain tumours. 
The 5 year survival for the study participants that were analysed was about 
37.5% 
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 Figure.9 shows the Kaplan-Meier survival curve for the study participants whose 
follow-up time was known. 
 
The general 5 year survival rate for the study participants who were analysed 
was about 37.5%.This is a low survival rate. 
 
4.9.1 Survival estimates by gender 
 
 
Figure 10 shows survival estimates by study participants’ gender. 
 
The curves show a slight better male survival rate than females. 
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Figure10 shows time to mortality curves by gender 
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4.9.2 Survival estimates by race 
 
Figure 11 shows survival estimates by race.  From the figure, one sees that the 
blacks survived longer than whites.  The other races were small for comparison. 
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Figure.11 shows survival curves by race  
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4.9.3  Survival estimates by Diagnosis. 
 
The survival analysis by diagnosis suggests that survival was longest among 
children with astrocytomas and craniopharyngiomas with about 55% 5-year 
survival, then medulloblastomas with about 45% 5-year survival and gliomas with 
about 20% 5-year survival.  The small number of participants for PNET, 
gangliogliomas and ependymoma makes it difficult to analyse.  
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Figure.12 shows survival curves by diagnosis 
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4.9.4  Survival estimates by treatment modalities 
 
Survival estimates were also carried out by treatment received (Figure 13).  The 
results indicate that survival is longest for participants who had combination of 
surgery, chemotherapy and radiotherapy, with around 70% five-year survival.  
Survival was also high for participants who had surgery alone at about 55%five-
year survival while the worst was for chemotherapy alone, where there was no 
survivors by the end of second year, after diagnosis. 
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Figure 13 shows survival curves by treatment modalities. 
 
Figure legend 
Chemo=chemotherapy 
Radio=radiotherapy 
Sur=surgery 
 
 
CHAPTER FIVE 
 
 
Fig.13 shows survival estimates by different treatment modalities. 
Figure legend:  
S r=    Surgery;  
Chemo=  Chemotherapy;  
Radio=  Radiotherapy;  
Sur/chemo=  Surgery/Chemotherapy;  
Sur/radio=  Surgery/Radiotherapy;  
Chemo/radio= Chemotherapy/Radiotherapy; 
Sur/chemo/radio=  Surgery/Chemotherapy/Radiotherapy  
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5.0 DISCUSSION 
 
Epidemiology of primary paediatric brain tumours has been studied extensively in 
the developed countries.  Studies from these countries show that these brain 
tumours are the most common group of solid tumours in childhood1,2,3,8.  Different 
epidemiological details of the children harbouring primary brain tumours have 
also been analysed in those studies.  Such studies are few or lacking in the 
developing countries especially in sub-saharan Africa. 
 
This study analysed epidemiological data of the study participants and the 
following is a discussion of the findings on each item and comparison with other 
studies is done. 
 
5.1 AGE, GENDER AND RACE IN RELATION TO CHILDHOOD BRAIN 
TUMOURS 
 
5.1.1 Age 
 
The mean age of study participants was 7.1 years.  This is lower than the 
findings in other studies10,12. 
 
The findings of this study show that different types of tumours affect different 
ages and age groups differently. 
 
For example, medulloblastomas were found to be commonest among children 
aged between 2 years and 9 years.   
 
Gliomas included mainly brainstem gliomas which were over 90%.  The others 
were thalamic gliomas. These tumours were diagnosed clinically and by 
radiological techniques because of their deep location in the brain In this study, 
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gliomas were commonest between ages of 2 years and 6 years and there were 
no children diagnosed with gliomas above the age of 12 years. 
 
Astrocytomas affected all age groups but peaked in age group 2 to 6 years and 
started slowly to decline.  
 
Ependymomas affected all age groups but peaked in the age group of 2 to 6 
years and then peaked again in the age group of 9 to 12 years.  
 
Craniopharyngiomas affected mainly ages between 2 to 12 years.  
 
Pineoblastomas were common among ages between the age 6 to 14 years. 
 
PNETs other than medulloblastomas and pineoblastomas affected mainly 
children of ages between 2 to 12 years, and were uncommon between the age 
group of 0 to 2 years and 12 to 14 years.   
The numbers for pituitary adenomas, meningiomas and gangliogliomas were too 
small to be analysed. 
 
Age was found to have significant impact on the distribution of primary childhood 
brain tumours between the supratentorial and infratentorial regions.  The mean 
age of the subjects who had brain tumours in the supratentorial location was 
significantly higher than the mean age of those who had brain tumours in the 
infratentorial location; (7.9 ± 0 45) and (6.4 ± 0.32) (p=0.009) respectively. 
Data from this study demonstrates that older children above seven years are 
more likely to suffer from supratentorial tumours than children less than seven 
years. In fact the mean age in years of the children with supratentorial tumours 
was approximately eight years compared to the mean age of children suffering 
from infratentorial tumours, which was about six years. This study also shows 
that childhood brain tumours are commoner among children younger than 7 
years.(54.5% below 7 years compared to 45.5% above 7 years).  When age was 
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categorized into two, with children less than seven years and those above seven 
years, children above seven years were 2.4 times more likely to develop 
supratentorial tumours than children younger than seven years.  Similarly, 
Mellisa and Julianne8 in their study found that the overall prevalence of central 
nervous tumours was highest in children younger than 8 years of age. 
 
5.1.2 Gender 
 
There were more males than females in this study, although not significantly 
different, with a male to female ratio of 1.04:1.  Although this study found a slight 
male predominance, other studies show a clear male predominance among 
children with brain tumours5,7,8,10,11. 
 
5.1.3 Race 
 
Data from this study on race distribution of paediatric brain tumours show 
majority being blacks (80.9%), followed by whites (15.1%), with coloured (2.2%) 
and the Asians(1.8%) being the least.  This is in contrast with studies from the 
USA8 and Britain4 where white children were more affected by brain tumours 
than their black counterparts.  Looking at these studies, one may attribute the 
differences to the racial demographics of these countries; in South Africa and in 
particular Greater Johannesburg metropolitan area18, african blacks constituted 
73%, whites 16%, coloured 6% and asians 4%.  On the other hand, in the UK15, 
whites are the majority constituting 92%, asians 4.4%, blacks 2% and others 
2.6%.  In the USA16, the majority are also whites constituting 73.9%, black 
americans 12.2%, asians 4.4%, alaskan natives 0.14% and mixed races 6.3%. 
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5.2 THE PREVALENCE OF PRIMARY PAEDIATRIC BRAIN TUMOURS 
 
The commonest primary paediatric brain tumours in this study were 
astrocytomas followed by medulloblastomas.  This was true for most studies that 
were reviewed2,4,5,7,8,14.  However, Gyasi and Tettey10 in their study found 
gliomas and meningiomas to be the most common childhood brain tumours.  On 
the other hand, Peacock et al13 found medulloblastomas, followed by brainstem 
gliomas to be more common. 
 
5.3 TYPES FREQUENCY AND ANATOMIC LOCATIONS OF PAEDIATRIC 
BRAIN TUMOURS 
 
Infratentorial tumours were the commonest compared to supratentorial tumours; 
67% and 33% respectively. This predominance of infratentorial tumours over 
supratentorial tumours was reported by other authors.3,6,13.  However, the 
difference in numbers of tumours between the infratentorial and supratentorial 
regions was higher than in any other study.  The closest was a study from Cape 
Town13 where infratentorial tumours were 63% and supratentorial tumours were 
37%.  Contrary to the above findings, Kaatsch et al6 reported a near equal 
distribution of tumours between supratentorial and infratentorial regions and Suh 
et al7 in their study reported that more tumours were found in supratentorial 
(68%) than in the infratentorial region (42%).   
 
In the infratentorial region, medulloblastomas (34%) were the commonest 
followed by brainstem gliomas (30%), astrocytomas (19%), ependymomas (12%) 
and PNET other than medulloblastomas (5%).  The Cape Town study13 also 
found medulloblastomas (41.8%) were commonest followed by brainstem 
gliomas(25.3%), ependymomas(16.5%) and cerebellar astrocytomas(16.5%).  
This was contrary to some studies in the literature6 where ependymomas (56%) 
were commonest followed by astrocytomas (44%)   
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In supratentorial region, the commonest tumours were craniopharyngiomas 
(36.6%) followed by pineoblastomas (25.4%), astrocytomas (21.1%), thalamic 
gliomas (4.2%), and others (12.6%).  Peacock et al13 in their study also found 
craniopharyngiomas to be the commonest tumours in the supratentorial region. 
 
5.4 TREATMENT MODALITIES USED IN MANAGEMENT OF PAEDIATRIC 
BRAIN TUMOURS 
 
Majority of the study participants (95.8%) had surgery as part of their treatment 
but surgical intervention alone was offered to about one half of that number 
(49.2%).  During surgery, either a total tumour was removed and required no 
other treatment or surgery was followed by other treatment modalities; 
radiotherapy or chemotherapy or a combination of the two modalities.  This was 
reported to be the practice in other studies13. 
 
Ten percent of the participants received radiotherapy alone.  These were children 
diagnosed with brainstem gliomas and thalamic gliomas and were above 3 years 
of age. 
Chemotherapy alone was offered to 3.4% of the study population and was used 
for subjects who had braistem gliomas but were 3 years or younger and could 
not receive radiotherapy. 
 
Combination therapy of chemotherapy and radiotherapy was given to subjects 
with gliomas who were older than 3 years.  In this study group combination 
therapy comprised 2.2%.  This modality of treatment for brainstem gliomas was 
confirmed in literature13. 
 
Combination therapy comprising surgery, chemotherapy and radiotherapy was 
offered to 10% of the study participants.  These were children with malignant 
tumours like medulloblastomas and ependymomas. 
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5.5 MORTALITY AND SURVIVAL RATES ASSOCIATED WITH 
CHILDHOOD BRAIN TUMOURS  
 
This study shows mortality incidence rate being slightly higher (non-significant) 
among whites 32.6 per 100 person years( CI 16.8-58.9) compared to 26.2per 
100 person years for blacks whereas in the literature mortality was the same for 
white and black children8.   
The numbers for Asians and coloured were too small for analysis.   
 
Also, this study showed that there was a non significant mortality incidence 
difference with more females than males dying, 29.1 and 27.8 per 100 person 
years respectively.  
Contrary to the above findings, Kaatsch et al6 reported a slightly better prognosis 
for girls than boys. 
 
This report also shows mortality incidence rate being highest among children with 
gliomas (67.8 per 100 person years) followed by ependymomas (65.2 per 100 
person years) and pineoblastomas, (32.9 per 100 person years). 
Craniopharyngiomas, medulloblastomas and astrocytomas had low mortality 
incidence rates (18.8,16.0 and 15.6 per 100 person years) respectively. 
 
The overall five year survival rate for the study participants was 37.5%.  This is 
much lower than that seen in the developed countries5,6,8. 
Looking at individual tumours, astrocytomas and craniopharyngiomas had the 
longest 5-year survival (55%), followed by medulloblastomas (45%).  This is still 
very low  compared to that in literature5,6,8. 
Speculation as to why there was high mortality rates among children treated for 
childhood tumours in this study include: 
● Low social economic status and cultural beliefs: Some parents and caregivers 
do not consider taking children to hospital when they are ill as the first thing to 
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do.  They take them to traditional healers first and only when there is no 
response to the traditional healer’s treatment the child is taken to hospital.   
Sometimes there may be no money to take a child to hospital for treatment or 
for follow-up: 
● Late presentation.  Many children present with advanced disease and this 
makes it difficult to treat these children and reduces their time of survival. 
● Lack of specialized paediatric neurosurgical units may be a big contributing 
factor in low survival outcomes.  This may be due to divided attention and 
resources while the children are under the care of general neurosurgical 
units. 
 
5.6 LIMITATIONS OF STUDY 
 
The study participant numbers were small as to make reasonable conclusions 
from it.  A bigger study needs to be carried out so that firmer conclusions can be 
made. 
 
There was incomplete data in patients’ records and this led to exclusion of many 
patients, almost one third of the children who had brain tumours were excluded. 
 
Loss of patients to follow-up was also found to be a major problem in this study; 
half of the study participants were lost to follow-up. 
  
Grading of tumours that have grades like astrocytomas, ependymomas was not 
stated.  This might have affected the outcome results negatively where high 
grade tumours were compared with low grade ones. 
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CHAPTER SIX 
 
 
CONCLUSIONS AND RECOMMENDATIONS 
 
 
6.1 Introduction 
 
This study is hospital based and carries the limitations of hospital based studies. 
However, important conclusions and recommendations can be made. 
 
6.2 Conclusions 
 
● The average age of children who had primary brain tumours was 7.1 
years. 
 
● The average age of children with infratentorial tumours was 6 years while 
that for children with supratentorial tumours was 8 years. 
 
● The older the child the higher was the likelihood of being diagnosed with 
supratentorial tumour than infratentorial tumour.  Over 7 years of age a 
child was 2.4 times more likely to have a supratentorial tumour than 
infratentorial tumour. 
 
● There was a slight male predominancy amongst children with primary 
brain tumours. 
 
● Primary paediatric brain tumours prevalence, in general, follows 
population demographics.  This is evident in this study and studies from 
the USA and Britain that looked at race and prevalence of the tumours.  In 
the USA and Britain these tumours are more common among white 
children than among black children while in this study blacks are more 
affected than whites. 
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● The common supratentorial tumours were craniopharyngiomas, 
astrocytomas and pineoblastomas in that order of frequency while the 
common infratentorial tumours were medulloblastomas, brainstem gliomas 
and astrocytomas in descending order of frequency. 
 
● The treatment modalities were similar to those given in similar patients in 
the literature.   
 
● There was very high mortality rate and poor survival rates than those 
recorded in the literature.  
 
● There was very poor patients follow-up. 
 
● Record keeping was inadequate. 
 
6.3 Recommendations  
 
● A much bigger follow up study needs to be undertaken to confirm or 
disprove the above findings. 
 
● Record keeping in the two hospitals needs to be improved. 
 
● There is need to establish a specialized paediatric unit which will help start 
a paediatric team comprising paediatric neurosurgeon(s), paediatric 
oncologist(s), paediatric intensivist(s) and neuroradiologist(s) with the 
dedicated paediatric neuro ICU.  Such a team given resources will 
improve survival outcome of children with brain tumours. 
 
● Public awareness about childhood brain tumours should  be improved by 
teaching public the symptoms and signs of these diseases.  Also making 
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the public aware that when these tumours are diagnosed early, the 
treatment outcome is much better. 
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ANNEXURE ONE 
 
SHOWS DATA COLLECTION SHEET. 
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DATA COLLECTION SHEET 
 
CODE 
NO 
DATE 
OF 
DIAGN
OSIS 
AGE SEX RACE DIAGNOSIS ANATOMIC
LOCATION 
TREATMENT 
GIVEN 
FOLLOW-
UP 
 PERIOD 
OUTCOME 
1          
2          
3          
4          
5          
6          
7          
8          
9          
10          
11          
12          
13          
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ANNEXURE TWO. 
 
SHOWS ETHICS COMMITTEE CLEARENCE CERTIFICATE 
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ANNEXURE THREE 
 
SHOWS PERMISSION LETTER FROM BARAGWANATH HOSPITAL 
ADMINISTRATION AUTHORISING USE OF PATIENTS’ RECORDS. 
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ANNEXURE FOUR 
 
SHOWS LETTER OF PERMISSION FROM JOHANNESBURG 
HOSPITAL ADMINISTRATION AUTHORISING USE OF PATIENTS’ 
RECORDS. 
61
